Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC
Clinical trial NCT04241523 · UNKNOWN
Trial details
- NCT number
- NCT04241523
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.